Assay for measurement of intact B-type natriuretic peptide prohormone in blood

被引:111
作者
Giuliani, Isabelle
Rieunier, Francois
Larue, Catherine
Delagneau, Jean-Franois
Granier, Claude
Pau, Bernard
Ferriere, Marc
Saussine, Max
Cristol, Jean-Paul
Dupuy, Anne-Marie
Merigeon, Emmanuel
Merle, Delphine
Villard, Sylvie
机构
[1] Fac Pharm Montpellier, CNRS, UMR 5160, F-34093 Montpellier 5, France
[2] Bio Rad Labs Inc, Marnes La Coquette, France
[3] I2T, Montpellier, France
[4] HOp Arnaud de Villeneuve, Montpellier, France
[5] Hop Lapeyronie, Dept Biochim, F-34059 Montpellier, France
关键词
D O I
10.1373/clinchem.2005.061770
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: B-Type natriuretic peptide (BNP1-32) as well as the N-terminal fragment of the prohormone containing residues 1-76 (NT-proBNP(1-76)), both cleavage products of the precursor proBNP(1-108), are reported to be powerful markers for prognosis and risk stratification of heart failure. However, the intact precursor also circulates in the bloodstream. Assays for the detection of these cleavage products have been developed, but most of these assays may overestimate the concentrations of the cleavage products because they also measure the precursor form. It is therefore important to develop an immunoassay that specifically measures solely proBNP(1-108) in plasma. Methods: After carefully designing the peptide used to immunize mice, we selected a specific monoclonal antibody (mAb Hinge76) that recognizes the cleavage site of proBNP(1-108), an epitope present only in the precursor form. mAb Hinge76 recognizes recombinant proBNP(1-108) in a dose-dependent manner, without any significant cross-reactivity with either recombinant NT-proBNP(1-76) or synthetic BNP1-32. By combining mAb Hinge76 with a polyclonal antibody directed against BNP1-32, we were able to set up a proBNP(1-108)-specific sandwich immunoassay able to confirm the presence of proBNP(1-108) in blood samples. Results: From a cohort of 50 healthy persons and 170 patients with congestive heart failure (CHF), our assay was able to differentiate healthy individuals from CHF patients (P < 0.005). Interestingly, plasma proBNP(1-108) concentrations were correlated with New York Heart Association classification. Moreover, a close relationship between proBNP(1-108) and BNP1-32 concentrations may exist, as a good correlation (r(2) = 0.89) was obtained when their respective concentrations were compared. Conclusion: mAb Hinge76 is the first proBNP(1-108)-specific mAb produced that allows accurate estimation of proBNP(1-108) concentrations in plasma. (c) 2006 American Association for Clinical Chemistry.
引用
收藏
页码:1054 / 1061
页数:8
相关论文
共 32 条
  • [1] Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides
    Ala-Kopsala, M
    Magga, J
    Peuhkurinen, K
    Leipälä, J
    Ruskoaho, H
    Leppäluoto, J
    Vuolteenaho, A
    [J]. CLINICAL CHEMISTRY, 2004, 50 (09) : 1576 - 1588
  • [3] Quality specifications for B-type natriuretic peptide assays
    Apple, FS
    Panteghini, M
    Ravkilde, J
    Mair, J
    Wu, AHB
    Tate, J
    Pagani, F
    Christenson, RH
    Jaffe, AS
    [J]. CLINICAL CHEMISTRY, 2005, 51 (03) : 486 - 493
  • [4] Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma B-type natriuretic peptide (BNP) and N-terminal proBNP
    Clerico, A
    Prontera, C
    Emdin, M
    Passino, C
    Storti, S
    Poletti, R
    Zyw, L
    Zucchelli, GC
    [J]. CLINICAL CHEMISTRY, 2005, 51 (02) : 445 - 447
  • [5] A RAPID AND POTENT NATRIURETIC RESPONSE TO INTRAVENOUS-INJECTION OF ATRIAL MYOCARDIAL EXTRACT IN RATS
    DEBOLD, AJ
    BORENSTEIN, HB
    VERESS, AT
    SONNENBERG, H
    [J]. LIFE SCIENCES, 1981, 28 (01) : 89 - 94
  • [6] A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure
    Doust, JA
    Glasziou, PP
    Pietrzak, E
    Dobson, AJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (18) : 1978 - 1984
  • [7] How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
    Doust, JA
    Pietrzak, E
    Dobson, A
    Glasziou, PP
    [J]. BRITISH MEDICAL JOURNAL, 2005, 330 (7492): : 625 - 627
  • [8] SPOT-SYNTHESIS - AN EASY TECHNIQUE FOR THE POSITIONALLY ADDRESSABLE, PARALLEL CHEMICAL SYNTHESIS ON A MEMBRANE SUPPORT
    FRANK, R
    [J]. TETRAHEDRON, 1992, 48 (42) : 9217 - 9232
  • [9] Goetze JP, 2002, CLIN CHEM, V48, P1035
  • [10] GRANIER C, 2005, CELL BIOL LAB HDB, P519